baber/WOPTO huggingface dataset:
Patent MX-PA03001333-A (MX)
Title: Butinol i esterase.
Inventor: HAUER BERNHARD
IPC: C12N1/19
Filed: 2001-08-30
Abstract: The invention relates to novel proteins from Pseudomonas glumae, having esterase activity, in particular butynol I esterase activity, to nucleic acid sequences coding therefore, to expression cassettes, vectors and recombinant microorganisms; to methods for preparing said proteins and to the use thereof for enzymic, in particular enantioselective enzymic, ester hydrolysis or transesterification of organic esters.
Patent MX-PA03004998-A (MX)
Title: Compact fuel processor for producing a hydrogen rich gas.
Inventor: WOLFENBARGER JAMES K
IPC: C10J1/207
Filed: 2001-12-05
Abstract: A reactor module for use in a compact fuel processor, comprising: 
a catalyst bed; a cooling coil positioned substantially within the catalyst bed for removing excess heat during normal operation; and an electrical heating element positioned within the cooling coil, the heating element capable of heating the catalyst to a desired reaction temperature.
Patent MX-PA03006297-A (MX)
Title: Copolymers of olefins and vinyl- and allylsilanes.
Inventor: STEVEN DALE ITTEL
IPC: C08F230/08
Filed: 2002-11-15
Abstract: Ethylene and allyl- or vinylsilanes are efficiently copolymerized by certain late transition metal complexes containing selected bidentate or tridentate ligands. The resulting novel polymers may be crosslinked by moisture when vinylsilane contains groups bound to silicon which are hydrolyzable. The polymers are useful for wire coating, crosslinked foams, pipes, and other uses.
Patent MX-PA03006353-A (MX)
Title: Disposable absorbent garment having improved appearance and sustained fit.
Inventor: FREDERICK MICHAEL LANGDON
IPC: A61F13/15
Filed: 2002-01-17
Abstract: Absorbent articles having improved sustained fit on the body, improved appearance through the period of use, and improved comfort for the wearer. The absorbent article has a containment assembly, a waist feature and a diagonal support member feature disposed so as to lie in the diagonal support zone of the wearer's body when the article is worn. The diagonal support member is designed to support the article from the small of the back, over the hip, and to the lower abdomen. The diagonal support member is distinct from the waist feature, which is designed to provide only enough circumferential tension to hold itself in position on the body. The absorbent article has a garment-like high-waisted appearance, gentle tension around the waist to avoid discomfort and/or pressure marking, good leakage protection, good sustained fit, and easy application and removal.
Patent MX-PA03008467-A (MX)
Title: Novel use of a peptide class of compound for treating non neuropathic inflammatory pain.
Inventor: SELVE NORMA
IPC: A61P25/04
Filed: 2002-03-19
Abstract: The present invention concerns the use of compounds of the Formula (I): <CHEM> for treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary inflammatory osteoarthritic pain. The compounds show an antinociceptive profile and differ from classical analgesics like opioids and non-steroidal anti-inflammatory drugs (NSAIDS) and are useful as specific analgesics.
Patent MX-PA03011412-A (MX)
Title: Alteration of oil traits in plants.
Inventor: ANTHONY J KINNEY
IPC: C07K14/415
Filed: 2002-06-27
Abstract: The preparation and use of nucleic acid fragments useful in altering the oil phenotype in plants are disclosed. Chimeric construct incorporating such nucleic acid fragments and suitable regulatory sequences can be used to create transgenic plants having altered lipid profiles. Methods for altering the oil phenotype in plants using such nucleic acid fragments also are disclosed.
Patent MX-PA03011585-A (MX)
Title: Flexible sleeve for connection to a plumbing fixture.
Inventor: AMADO GERARDO TRUJILLO VIRAMON
IPC: E03D11/16
Filed: 2003-12-11
Abstract: Disclosed herein is an improved water closet flange for connection to a plumbing fixture. The improved flange comprises an anchoring element or outer flange, connected to a flexible conduit tube or flexible sleeve, in which is attached an O-ring type of gasket. The improved flange connects a toilet bowl outlet to a waste drainpipe outlet without any flow reduction in between both connecting elements. The improved flange allows the connection between a toilet bowl discharge and a well placed vertical waste drainpipe. The improved flange also allows the connection between a toilet bowl discharge and a waste drainpipe outlet that is offset, horizontally oriented, or diagonally placed. The improved flange may further comprise an O-ring type of gasket disposed on the exterior of the flexible sleeve to provide a tight seal between the outer surface of the flexible sleeve and the inner surface of a waste drainpipe. The flexible sleeve can be implemented in a variety of sizes or diameters, in cluding, for example, 3 inch (7.5 cm) and 4 inch (10 cm) diameters. An alternative embodiment of the flexible sleeve can fit either 3 inch or 4 inch drainpipes with the help of an appropriate O-ring seal of the appropriate dimensions.
Patent MX-PA04000062-A (MX)
Title: Homocysteinylated transthyretin.
Inventor: PHILLIP E MARKS
IPC: H01B/
Filed: 2002-06-13
Abstract: The present invention is generally directed to the discovery of homocysteinylated proteins and its importance as an indicator of diseased states. In preferred embodiments of the present invention the isolation, detection, and use of homocysteinylated transthyretin are also provided. More preferably, detection and isolation of a homocysteinylated transthyretin complex from a biological fluid is provided in the present invention, as well as methods and compositions utilizing homocysteinylated transthyretin in the detection of homocysteine or elevated levels of homocysteine. More particularly, the present invention is directed to homocysteinylated transthyretin and its use as a marker for the diagnosis of homocysteinemia, hyperhomocysteinemia, and diseases associated therewith.
Patent MX-PA04001968-A (MX)
Title: Oral antidiabetic agents.
Inventor: CHRISTOPHER FRANKLIN BIGGE
IPC: C07D413/12
Filed: 2002-07-15
Abstract: The present invention provides compounds of Formula (I): f I wherein A, X, Q, Y, B, D, Z, and E have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful as antidiabetic agents. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, process for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.
Patent MX-PA04004516-A (MX)
Title: Apparatus and process for generating energy.
Inventor: HARRY PAUL SPRAIN
IPC: H02K21/14
Filed: 2002-11-12
Abstract: A machine (Figure 1) including a rotor (2) with permanent magnet (3) and a stator (4) with permanent magnets (5) disposed around the rotor with discontinuity space (6) and at least one electromagnet (7) The stator permanent magnets (5) are mounted on the stator (4) such that the distance between the rotor and each of the stator permanent magnets increases linearly.
Patent MX-PA04005794-A (MX)
Title: Tide-motive pump.
Inventor: GERARDO MONTALVO CORRAL
IPC: F03B13/14
Filed: 2004-05-31
Abstract: Described is a vertical displacing tide-motive pump, which is a system operated by the sea weaves energy, the waves providing the energy useful for generating the required water flow and pressure with regard to the pump design, since said pump requires a floating system designed according to the weight and size thereof, and to the cylinder (conduits) capacity as well as the capacity of a pressure and storage tank. The system further includes, as a main part, a wave generating channel actuated by an electric engine useful for impelling a generation ramp, the speed of said ramp being controlled as it is responsible of the required flow production. The purpose of the system is to pump water for supplying it to different activities, thus removing desalting components and assembling the required conduits to the pressure and storage tank in order to transport water or to carry out agricultural irrigation activities.
Patent MX-PA04006059-A (MX)
Title: Lyophilized preparation containing antibodies to the egf receptor.
Inventor: LUDWING KR GER
IPC: A61K47/26
Filed: 2002-11-25
Abstract: The invention relates to a lyophilized, pharmaceutical preparation containing an antibody to the receptor of the endothelial growth factor (EGF receptor). The preparation has an improved storage stability, even at high temperatures and once reconstituted, can be used parenterally for the treatment of tumours.
Patent MX-PA04009778-A (MX)
Title: Enhanced silk exsertion under stress.
Inventor: CHRISTOPHER ZINSELMEIER
IPC: C07K14/415
Filed: 2003-04-08
Abstract: The invention provides methods for enhancing maize silk exsertion under stress conditions and compositions relating to such methods, including nucleic acids and proteins. The invention further provides recombinant expression cassettes, host cells, and transgenic plants.
Patent MX-PA05000643-A (MX)
Title: Digital switching cross-connect module.
Inventor: KLUEMPKE SHARI K
IPC: H01R24/58
Filed: 2003-07-10
Abstract: A cross-connect module (120) is disclosed herein. The cross-connect module includes a housing (122) having a front end (126) and a rear end (128). The rear end (128) includes a rear wall (129) defining connector mounting openings (196). First and second switching jacks (134) are positioned adjacent the front end of the housing. Rear connectors (150) mount within the connector mounting openings (196). Cables (152) electrically couple the rear connectors to the switching jacks (134). A tracer lamp (156) circuit including a power connector and a pin jack (158) are also provided. In depicted embodiments, the rear connectors, the pin jack and the power connector are secured to the rear wall of the housing by snap-fit connect ions. The depicted module also includes a front cover (144) having structure for providing snap-fit connections with the switching devices.
Patent MX-PA05002278-A (MX)
Title: Low viscosity copper solvent extraction reagent formulations.
Inventor: OLAFSON STEPHEN M
IPC: C01B31/16
Filed: 2003-09-12
Abstract: A low viscosity water insoluble extraction reagent composition according to the invention is comprised of: (a) an extractant selected from the group consisting of an aldoxime, a ketoxime, or a combination thereof; (b) an equilibrium modifier having a Brookdield viscosity of equal to or less than about 5 centapoise at 25¦C and a flash point equal to or greater than about 141¦F wherein the molar ratio of modifier to extractant is from about 0.05 to about 2.0 so as to provide a net copper transfer greater than that achieved in the absence of modifier. Such low viscosity extractants afford higher recoveries of copper, permit reduced equipment size such as smaller mixers and settlers and the use of reduced amounts of less overall organic inventory.
Patent MX-PA05002758-A (MX)
Title: Atmosphere control during continuous heat treatment of metal strips.
Inventor: RENARD MICHEL
IPC: C21D1/76
Filed: 2003-09-11
Abstract: The invention concerns a method for metal strip heat treatment comprising: passing the strip inside a chamber through a heating zone, and a cooling zone, and establishing a first protective gas atmosphere containing nitrogen and a first hydrogen content in the chamber, except for the cooling zone, wherein is adjusted a second protective gas atmosphere containing nitrogen and a second hydrogen content higher than the first, introducing nitrogen into the chamber, injecting protective gas containing a third hydrogen content higher than said second content in said cooling zone, producing a gas exchange between one zone of the chamber having said first protective gas atmosphere and said cooling zone, and controlling the flow of said introduction and said injection.
Patent MX-PA05006150-A (MX)
Title: 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases.
Inventor: WANG HUI-LING
Filed: 2003-12-22
Abstract: Compounds of formula I are effective for treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involvong stroke, cancer and the like.
Patent MX-PA05010081-A (MX)
Title: Benzyl-pyridazinons as reverse transcriptase inhibitors.
Inventor: ZACHARY KEVIN SWEENEY
IPC: C07D401/12
Filed: 2004-03-17
Abstract: This invention relates to novel pyridazinone derivatives of formula (I) wherein R1-R4, R7, R8 and X1 are as defined in the summary and pharmaceutically acceptable salts and solvates thereof, methods to inhibit or modulate Human Immunodeficiency Virus (HIV) reverse transcriptase with compounds of formula (I), pharmaceutical compositions containing of formula (I) admixed with at least one solvent, carrier or excipient and processes to prepare compounds of formula (I). The compounds are useful for treating disorders in which HIV and genetically related viruses are implicated.
Patent MX-PA05014088-A (MX)
Title: Pharmaceutical compositions containing antihypertensive substances combined with platelet aggregation inhibiting substances for use in the treatment and prevention of ischemic vascular events.
Inventor: OCHOA VICTOR GUILLERMO ALVAREZ
IPC: A61K31/00
Filed: 2005-12-20
Abstract: The invention relates to the pharmaceutical industry in general and in particular to the pharmaceutical industry involved in the production of medicaments for controlling systemic arterial hypertension and preventing ischemic vascular events. More specifically, the invention relates to a composition containing a hypotensive antagonist substance of angiotensin II receptors which is combined with a platelet aggregation inhibiting agent. The composition is characterised in that the aforementioned combination or association consists of a selected angiotensin II receptor antagonist substance known as Losartan and a platelet aggregation inhibiting agent known as acetylsalicylic acid, in order to produce a product which has a synergistic effect for the treatment of systemic arterial hypertension and which prevents the risk of ischemic vascular events, with fewer side effects.
Patent MX-PA06000159-A (MX)
Title: Preparation of 1,3-diphenylprop-2-en-1-one derivatives.
Inventor: DELHOMEL JEAN-FRANCOIS
IPC: C07C69/712
Filed: 2004-07-08
Abstract: The invention relates to a method for the preparation of de 1,3-diphenylprop-2-en-1-one substituted on one of the two phenyl groups by a carboxyalkyloxy group or a carboxyalkylthio group.
Patent MX-PA06001516-A (MX)
Title: High performance non-zinc, zero phosphorus engine oils for internal combustion engines.
Inventor: DECKMAN DOUGLAS E
IPC: C10M163/00
Filed: 2004-08-10
Abstract: A substantially zinc and phosphorous free lubricating oil meeting engine performance requirements contain an additive system containing metal detergents, at least one borated ashless dispersant, at least an amine antioxidant and a trinuclear molybdenum compound. The lubricant contains a minimum of (120) ppm boron and a minimum of (80) ppm molybdenum.
Patent MX-PA06001596-A (MX)
Title: Aqueous pharmaceutical solution containing oxymetazoline and/or xylometazoline.
Inventor: TSCHAIKIN MARION
IPC: A61K31/4174
Filed: 2004-07-14
Abstract: The invention relates to a stable aqueous solution containing oxymetazoline and/or xylometazoline, a zinc salt, and a buffer salt. The inventive aqueous solution is particularly suitable for local administration into the nose as a decongestant.
Patent MX-PA06001726-A (MX)
Title: Method for the preparation of group ib-iiia-via quaternary or higher alloy semiconductor films.
Inventor: ALBERTS VIVIAN
IPC: H01L31/18
Filed: 2004-08-13
Abstract: This invention relates to a method for producing group IB-IIIA-VIA quaternary or higher alloy semiconductor films wherein the method comprises the steps of (i) providing a metal film comprising a mixture of group IB and group IIIA metals; (ii) heat treating the metal film in the presence of a source of a first group VIA element (said first group VIA element hereinafter being referred to as VIA1 ) under conditions to form a first film comprising a mixture of at least one binary alloy selected from the group consisting of a group IB -VIA1 alloy and a group IIIA --VIA1 alloy and at least one group IB-IIIA-VIA1 ternary alloy (iii) optionally heat treating the first film in the presence of a source of a second group VIA element (said second group VI element hereinafter being referred to as VIA2) under conditions to convert the first film into a second film comprising at least one alloy selected from the group consisting of a group IB-VIA1-VIA2 alloy and a group IIIA-VIA1-VIA2 alloy; and the at least one group IB- -III-VIA1 ternary alloy of step (ii); (iv) heat treating either the first film or second film to form a group IB-IIIA-VIA quaternary or higher alloy semiconductor film.
Patent MX-PA06003552-A (MX)
Title: Indanyl-piperazine compounds.
Inventor: GOBERT ALAIN
IPC: C07D207/16
Filed: 2006-03-30
Abstract: A compound selected from those of formula (1): wherein R3 represents a hydrogen atom, and R1 and R2 together with the carbon atoms carrying them form a benzene, naphthalene or quinoline ring structure, each of the ring structures being optionally substituted, or R1 represents a hydrogen atom, and R2 and R3 together with the carbon atoms carrying them form a ring structure, each nally substituted, n represents 1 or 2 -X- represents a group selected from -(CH2)m -O-Ak-, (CH2)m-NR4-Ak-, -(CO)-NR4-Ak- y -(CH2)m-NR4-(CO)-, m represents an integer between 1 and 6 inclusive, Ak represents an optionally substituted alkylene chain, and R4 represents a hydrogen atom or an alkyl group, Ar represents an aryl or heteroaryl group, its enantiomers, diasteroisomers, and addition salts thereof with a pharmaceutically acceptable acid..
Patent MX-PA06004616-A (MX)
Title: Method of determining the natural drive indices and of forecasting the performance of the future exploitation of an oil pool.
Inventor: MEZA MAXIMINO MEZA
IPC: E21B47/06
Filed: 2006-04-26
Abstract: The invention relates to a method of determining the drive indices and the original volume of hydrocarbons and of forecasting the future exploitation of an initially-undersaturated oil pool. The aforementioned indices are determined using the natural forces of gravity, viscosity and capillarity. In addition, the geological characteristics of the rock, expansion of the gas cap and the entry of water from the aquifer are also taken into account. The inventive method is based on the gradually-diminishing performance of the pressure in relation to the accumulated production of the pool or, more specifically, to the diminishing linear performance with marked variations in the slope of the pressure logarithm in relation to the accumulated production. Variations in the slope indicate variations in the natural drive mechanism of the pool. According to the invention, the variation in the accumulated oil production in relation to the pressure given by the first slope is used to estimate the original volume, while subsequent variations in the slope are used to deduce analytically parameters associated with the pool, such as productivity, drive indices, expansion and injection of fluids in the pool. When a variation occurs in the drive mechanism, the net effect of the drive of the rock/fluid system in a pool is the difference between the existing slope and the previous slope at said moment, the variations in the accumulated production in all of said parameters being implicit in the conditions of the pool.
Patent MX-PA06006130-A (MX)
Title: Improved inversion of inverse emulsion polymers.
Inventor: VAYNBERG ABRAHAM K
IPC: C08J3/03
Filed: 2004-12-14
Abstract: A method to invert an inverse emulsion water compatible polymer product using a combination of surfactants that have specific chemical structures is disclosed. A combination, or blend, of two or more surfactants provides for an effective breaker system. The blend of surfactants is more effective than the individual surfactants.
Patent MX-PA06006769-A (MX)
Title: Oxazolidinone-quinolone hybrid antibiotics.
Inventor: MULLER STEFAN
IPC: A61P31/04
Filed: 2004-12-20
Abstract: The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria:.
Patent MX-PA06011173-A (MX)
Title: Beauty wash product compositions.
Inventor: LIPS ALEXANDER
IPC: A61K8/29
Filed: 2005-03-11
Abstract: The present invention relates to compositions delivering enhanced visual benefits to the skin with specific optical attributes. these are delivered using specific deposition system (where oil/emollient optionally comprises part of deposition system) and solid particulate optical modifiers.
Patent MX-PA06012942-A (MX)
Title: Low-calorie whole grain cereal bar .
Inventor: COLEMAN EDWARD C
IPC: A23L27/00
Filed: 2006-11-07
Abstract: A low-calorie whole grain cereal bars is provided that includes whole grain and binder in amounts effective for providing a cereal bar with at least about 15 weight % or more whole grain, at least about 5 weight % or more protein, about 5 weight % or more fiber, and at least 120 or less calories per 28 gram bar. The cereal bars are low in calories but still provide a good source of whole grain and fiber while maintaining an acceptable taste and organoleptic properties.
Patent MX-PA06013901-A (MX)
Title: Injection device.
Inventor: BARROW-WILLIAMS TIM
IPC: A61M5/00
Filed: 2005-05-27
Abstract: An injection device (210) is described. A housing (212) receives a syringe and includes a return spring (226) for biasing the syringe from an extended position in which its needle (218) extends from the housing to a retracted position in which the it does not. A drive spring (230) acts on a first drive element (232) and a second drive element (234) acts upon the syringe to advance it from its retracted position to its extended position and discharge its contents through the needle. The first drive element is capable of movement relative to the second once a nominal decoupling position has been reached. A release mechanism is activated when the-first drive element is further advanced to a nominal release position, to release the syringe (214) from the action of the drive spring, whereupon the return spring restores the syringe to its retracted position. A locking mechanism (337, 375) confines the returned syringe in its retracted position.
Patent MY-101441-A (MY)
Title: Reinforcing structural material and reinforced structure reinforced therewith
Inventor: OKAMOTO TADASHI
IPC: B28B23/00
Filed: 1987-09-25
Abstract: THERE IS DISCLOSED A REINFORCING STRUCTURAL MATERIAL (1) COMPRISING A PLURALITY OF FIBRE CORDS (3), EACH COMPRISING A PLURALITY OF FIBRES (2) FORMED INTO A BRAID (4), THE BRAID (4) BEING IMPREGNATED WITH A BONDING AGENT (5). THE REINFORCING STRUCTURAL MATERIAL (1) CAN BE USED TO REINFORCE A MOULDED INORGANIC COMPOSITE. (FIG. 2)
Patent MY-102040-A (MY)
Title: An outdoor unit for an air conditioning apparatus of a through-the-wall multitype.
Inventor: TADASHI KOBAYASHI
IPC: F25D19/00
Filed: 1987-09-28
Abstract: AN OUTDOOR UNIT A, FOR AN AIR CONDITIONING APPARATUS OF A THROUGH - THE- WALL MULTITYPE, IS INSTALLED WITHIN AN INSTALLATION OPENING 51 FORMED THROUGH A WALL 50 OF A ROOM, SO THAT HEAT- EXCHANGE OF OURDOOR COILS 10 IS CONDUCTED OUTSIDE THE ROOM WHEREAS CONNECTION JOINTS 18 AND 19 BETWEEN THE OUTDOOR UNIT A AND INDOOR UNITS ARE EASILY ACCESSIBLE FROM INSIDE THE ROOM.(FIG. 1)